2023 Q3 Form 10-Q Financial Statement

#000173112223001728 Filed on September 25, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2022 Q3
Revenue $124.7K $135.0K
YoY Change -7.7% 22.24%
Cost Of Revenue $76.48K $56.22K
YoY Change 36.03% 10.87%
Gross Profit $48.17K $78.82K
YoY Change -38.89% 31.88%
Gross Profit Margin 38.64% 58.37%
Selling, General & Admin $124.9K $115.8K
YoY Change 7.94% 73.16%
% of Gross Profit 259.38% 146.86%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $769.00 $370.00
YoY Change 107.84% -95.56%
% of Gross Profit 1.6% 0.47%
Operating Expenses $201.4K $172.0K
YoY Change 17.12% 157.26%
Operating Profit -$76.77K -$36.93K
YoY Change 107.87% 421.65%
Interest Expense $6.421K $10.71K
YoY Change -40.05% -179.81%
% of Operating Profit
Other Income/Expense, Net -$7.190K $249.3K
YoY Change -102.88% 640.83%
Pretax Income -$83.96K $212.4K
YoY Change -139.54% 1514.9%
Income Tax
% Of Pretax Income
Net Earnings -$83.96K $212.4K
YoY Change -139.54% 1514.88%
Net Earnings / Revenue -67.36% 157.25%
Basic Earnings Per Share $0.00 $0.01
Diluted Earnings Per Share $0.00 $0.01
COMMON SHARES
Basic Shares Outstanding 36.18M shares 33.85M shares
Diluted Shares Outstanding 36.63M shares 34.90M shares

Balance Sheet

Concept 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $178.8K $159.5K
YoY Change 12.11% -51.21%
Cash & Equivalents $178.8K $159.5K
Short-Term Investments
Other Short-Term Assets $10.45K
YoY Change -74.13%
Inventory $588.9K $531.5K
Prepaid Expenses
Receivables $82.00 $9.613K
Other Receivables $0.00 $0.00
Total Short-Term Assets $767.8K $971.1K
YoY Change -20.93% 5.39%
LONG-TERM ASSETS
Property, Plant & Equipment $24.25K $6.332K
YoY Change 282.93% -87.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $733.1K $657.2K
YoY Change 11.56% -1.49%
Total Long-Term Assets $757.4K $663.5K
YoY Change 14.15% -7.56%
TOTAL ASSETS
Total Short-Term Assets $767.8K $971.1K
Total Long-Term Assets $757.4K $663.5K
Total Assets $1.525M $1.635M
YoY Change -6.69% -0.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $275.5K $294.3K
YoY Change -6.39% 45.51%
Accrued Expenses $3.778K $5.223K
YoY Change -27.67% -91.19%
Deferred Revenue
YoY Change
Short-Term Debt $71.67K $119.6K
YoY Change -40.09% -66.03%
Long-Term Debt Due $20.27K $18.63K
YoY Change 8.8% 0.0%
Total Short-Term Liabilities $425.3K $488.7K
YoY Change -12.99% -22.96%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $66.67K
YoY Change -100.0% -7.05%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $49.53K $137.8K
YoY Change -64.05% 67.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $425.3K $488.7K
Total Long-Term Liabilities $49.53K $137.8K
Total Liabilities $474.8K $626.5K
YoY Change -24.22% -12.56%
SHAREHOLDERS EQUITY
Retained Earnings -$10.59M -$10.31M
YoY Change 2.77%
Common Stock $11.64M $11.31M
YoY Change 2.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.050M $1.008M
YoY Change
Total Liabilities & Shareholders Equity $1.525M $1.635M
YoY Change -6.69% -0.28%

Cashflow Statement

Concept 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$83.96K $212.4K
YoY Change -139.54% 1514.88%
Depreciation, Depletion And Amortization $769.00 $370.00
YoY Change 107.84% -95.56%
Cash From Operating Activities $48.76K $15.85K
YoY Change 207.63% 9.69%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$73.00K -$7.370K
YoY Change 890.5%
Cash From Investing Activities -$73.00K -$7.370K
YoY Change 890.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 138.0K -68.73K
YoY Change -300.84% -175.04%
NET CHANGE
Cash From Operating Activities 48.76K 15.85K
Cash From Investing Activities -73.00K -7.370K
Cash From Financing Activities 138.0K -68.73K
Net Change In Cash 113.8K -60.25K
YoY Change -288.88% -156.82%
FREE CASH FLOW
Cash From Operating Activities $48.76K $15.85K
Capital Expenditures $0.00
Free Cash Flow $48.76K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001190370
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q3 ivdn Common Stock To Be Issued
CommonStockToBeIssued
usd
CY2022Q4 ivdn Common Stock To Be Issued
CommonStockToBeIssued
usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
ivdn Proceeds On Notes Payable
ProceedsOnNotesPayable
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-07-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-51791
dei Entity Registrant Name
EntityRegistrantName
INNOVATIVE DESIGNS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
03-0465528
dei Entity Address Address Line1
EntityAddressAddressLine1
124 Cherry Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Pittsburgh
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
15223
dei City Area Code
CityAreaCode
(412)
dei Local Phone Number
LocalPhoneNumber
799-0350
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
true
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36417560 shares
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
178817 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
263293 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
82 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11203 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
588874 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
494580 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
767773 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
769076 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24247 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5960 usd
CY2023Q3 ivdn Inventory On Consignment
InventoryOnConsignment
0 usd
CY2022Q4 ivdn Inventory On Consignment
InventoryOnConsignment
1625 usd
CY2023Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
0 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
80000 usd
CY2023Q3 ivdn Advance To Employee Noncurrent
AdvanceToEmployeeNoncurrent
13200 usd
CY2022Q4 ivdn Advance To Employee Noncurrent
AdvanceToEmployeeNoncurrent
13200 usd
CY2023Q3 us-gaap Deposits On Flight Equipment
DepositsOnFlightEquipment
719944 usd
CY2022Q4 us-gaap Deposits On Flight Equipment
DepositsOnFlightEquipment
607370 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
733144 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
702195 usd
CY2023Q3 us-gaap Assets
Assets
1525164 usd
CY2022Q4 us-gaap Assets
Assets
1477231 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
275487 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
162063 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
20265 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
20128 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
54073 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
46345 usd
CY2023Q3 ivdn Current Portion Of Stockholder Loans
CurrentPortionOfStockholderLoans
71668 usd
CY2022Q4 ivdn Current Portion Of Stockholder Loans
CurrentPortionOfStockholderLoans
110631 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3778 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3778 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
425271 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
342945 usd
CY2023Q3 ivdn Longterm Portion Of Due To Stockholders
LongtermPortionOfDueToStockholders
49530 usd
CY2022Q4 ivdn Longterm Portion Of Due To Stockholders
LongtermPortionOfDueToStockholders
64547 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
66667 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
49530 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
131214 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100800000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100800000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36092560 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36092560 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34650560 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34650560 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
3612 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
3467 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
11637980 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
11335184 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10591228 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10335579 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1050363 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1003072 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1525164 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1477231 usd
CY2023Q3 us-gaap Revenues
Revenues
124650 usd
CY2022Q3 us-gaap Revenues
Revenues
135048 usd
us-gaap Revenues
Revenues
223546 usd
us-gaap Revenues
Revenues
235164 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
76480 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
56224 usd
us-gaap Cost Of Revenue
CostOfRevenue
106839 usd
us-gaap Cost Of Revenue
CostOfRevenue
109884 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
124944 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
115384 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
359917 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
545212 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
201424 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
171608 usd
us-gaap Operating Expenses
OperatingExpenses
466756 usd
us-gaap Operating Expenses
OperatingExpenses
655096 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-76774 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-36560 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-243210 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-419932 usd
CY2023Q3 ivdn Miscellaneous Income Expense
MiscellaneousIncomeExpense
0 usd
CY2022Q3 ivdn Miscellaneous Income Expense
MiscellaneousIncomeExpense
260000 usd
ivdn Miscellaneous Income Expense
MiscellaneousIncomeExpense
7519 usd
ivdn Miscellaneous Income Expense
MiscellaneousIncomeExpense
260000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
6421 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
10710 usd
us-gaap Interest Expense
InterestExpense
17652 usd
us-gaap Interest Expense
InterestExpense
34450 usd
CY2023Q3 us-gaap Depreciation
Depreciation
769 usd
CY2022Q3 us-gaap Depreciation
Depreciation
373 usd
us-gaap Depreciation
Depreciation
2306 usd
us-gaap Depreciation
Depreciation
1118 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7190 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
248917 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12439 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
224432 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-83964 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
212357 usd
us-gaap Profit Loss
ProfitLoss
-255649 usd
us-gaap Profit Loss
ProfitLoss
-195500 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.002
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.006
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.007
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.006
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35656821 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33845560 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35339663 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33845560 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.002
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.006
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.007
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.006
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36633430 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34902893 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36153406 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34902893 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1003072 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
110000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
5940 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-59094 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1059918 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-112591 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
947327 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
141000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
10000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
36000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-83964 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1050363 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
932361 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
61000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
10000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-132040 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
871321 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25200 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
175000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-275816 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
795705 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
212357 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1008062 usd
us-gaap Profit Loss
ProfitLoss
-255649 usd
us-gaap Profit Loss
ProfitLoss
-195500 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
41940 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
185000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2306 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1118 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
30510 usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
7519 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11121 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8412 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
92669 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-11104 usd
ivdn Increase Decrease In Deposits On Inventories
IncreaseDecreaseInDepositsOnInventories
80000 usd
ivdn Increase Decrease In Deposits On Inventories
IncreaseDecreaseInDepositsOnInventories
-40000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
260000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
113424 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
45826 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
7728 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-2640 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-99318 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-232994 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20593 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
112574 usd
us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
7370 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7519 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-125648 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7370 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
261000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
86200 usd
ivdn Payments On Shareholder Advances
PaymentsOnShareholderAdvances
105630 usd
ivdn Payments On Shareholder Advances
PaymentsOnShareholderAdvances
135667 usd
ivdn Payment On Lease Liability
PaymentOnLeaseLiability
-0 usd
ivdn Payment On Lease Liability
PaymentOnLeaseLiability
30510 usd
ivdn Proceeds On Notes Payable
ProceedsOnNotesPayable
-1818 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
14880 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2418 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
140490 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-80577 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-84476 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-320941 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
263293 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
480451 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
178817 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159510 usd
us-gaap Interest Paid Net
InterestPaidNet
9924 usd
us-gaap Interest Paid Net
InterestPaidNet
37090 usd
ivdn Common Stock Issued For Services
CommonStockIssuedForServices
41940 usd
ivdn Common Stock Issued For Services
CommonStockIssuedForServices
185000 usd
us-gaap Basis Of Accounting
BasisOfAccounting
<p id="xdx_80D_eus-gaap--BasisOfAccounting_zwADpoXWTo55" style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 8.7pt">  </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 10.4pt"></td><td style="width: 18pt"><span style="font: 10pt Times New Roman, Times, Serif; letter-spacing: -0.05pt"><b>1.</b></span></td><td><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_826_zx2r3BZXcgm5">BASIS OF PRESENTATION</span></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.4pt; text-indent: -18pt"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 7.15pt 0 28.4pt; text-align: justify">In the opinion of management, the accompanying unaudited financial statements contain all adjustments necessary to present fairly Innovative Designs, Inc.’s (the “Company”) financial position as of July 31, 2023, the changes therein for the three and nine month periods then ended<span style="letter-spacing: -0.3pt"> </span>and<span style="letter-spacing: -0.3pt"> </span>the<span style="letter-spacing: -0.3pt"> </span>results<span style="letter-spacing: -0.45pt"> </span>of<span style="letter-spacing: -0.3pt"> </span>operations<span style="letter-spacing: -0.35pt"> </span>for<span style="letter-spacing: -0.4pt"> </span>the<span style="letter-spacing: -0.3pt"> </span>three<span style="letter-spacing: -0.3pt"> </span>and<span style="letter-spacing: -0.4pt"> </span>nine<span style="letter-spacing: -0.3pt"> </span>month<span style="letter-spacing: -0.3pt"> </span>periods<span style="letter-spacing: -0.35pt"> </span>ended July<span style="letter-spacing: -0.35pt"> </span>31,<span style="letter-spacing: -0.3pt"> </span>2023 and<span style="letter-spacing: -0.1pt"> </span>2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 7.15pt 0 28.4pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 7.25pt 0 28.4pt; text-align: justify">The<span style="letter-spacing: -0.25pt"> </span>financial<span style="letter-spacing: -0.25pt"> </span>statements<span style="letter-spacing: -0.25pt"> </span>included<span style="letter-spacing: -0.25pt"> </span>in<span style="letter-spacing: -0.35pt"> </span>the<span style="letter-spacing: -0.25pt"> </span>Form<span style="letter-spacing: -0.45pt"> </span>10-Q<span style="letter-spacing: -0.25pt"> </span>(the<span style="letter-spacing: -0.25pt"> </span>“Form”)<span style="letter-spacing: -0.35pt"> </span>are<span style="letter-spacing: -0.4pt"> </span>presented<span style="letter-spacing: -0.25pt"> </span>in<span style="letter-spacing: -0.25pt"> </span>accordance with the requirements of the Form and do not include all of the disclosures required by accounting principles generally accepted in the United States of America. For additional information, reference is made to the Company’s annual report on Form <span style="letter-spacing: 0.05pt">10-K </span>for the fiscal year ended October 31, 2022. The results of operations for the three and nine month periods ended July 31, 2023 and 2022 are not necessarily indicative of operating results for the full <span style="letter-spacing: -0.15pt">year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 7.25pt 0 28.4pt; text-align: justify"><span style="letter-spacing: -0.15pt"> </span></p>
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1627216 usd
us-gaap Depreciation
Depreciation
2306 usd
us-gaap Profit Loss
ProfitLoss
-255649 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-84476 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10591228 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5860 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11203 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5860 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
82 usd
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
75468 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
75468 usd
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
223546 usd
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
235164 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1486164 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
1820 usd
CY2023Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0260 pure
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
125741 usd
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
226793 usd
CY2023Q3 us-gaap Short Term Debt Percentage Bearing Fixed Interest Rate
ShortTermDebtPercentageBearingFixedInterestRate
0.10 pure
CY2022Q3 us-gaap Short Term Debt Percentage Bearing Fixed Interest Rate
ShortTermDebtPercentageBearingFixedInterestRate
0.12 pure
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
954000 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
994000 usd
us-gaap Depreciation
Depreciation
1118 usd
ivdn Shipping And Handling Costs
ShippingAndHandlingCosts
27070 usd
ivdn Shipping And Handling Costs
ShippingAndHandlingCosts
21199 usd
ivdn Deposits On Equipments
DepositsOnEquipments
112574 usd
CY2023Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
719944 usd
CY2022Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
607370 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0550 pure
ivdn Lease Rou Description
LeaseROUDescription
The Company entered into a lease for office space at the time the Company was formed through June 2022. Effective July 2022, the Company is leasing the office space on a month to month basis.
CY2022Q2 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
260000 usd

Files In Submission

Name View Source Status
ivdn-20230731_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ivdn-20230731_def.xml Edgar Link unprocessable
0001731122-23-001728-index-headers.html Edgar Link pending
0001731122-23-001728-index.html Edgar Link pending
0001731122-23-001728.txt Edgar Link pending
0001731122-23-001728-xbrl.zip Edgar Link pending
e5060_10q.htm Edgar Link pending
e5060_ex31-1.htm Edgar Link pending
e5060_ex31-2.htm Edgar Link pending
e5060_ex32-1.htm Edgar Link pending
e5060_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ivdn-20230731.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
ivdn-20230731_lab.xml Edgar Link unprocessable
ivdn-20230731_pre.xml Edgar Link unprocessable
e5060_10q_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending